| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 06/22/2005 | EP1544214A1 Non-neutralizing anti-apc antibodies |
| 06/22/2005 | EP1543034A2 Treatment and prophylaxis with 4-1bb-binding agents |
| 06/22/2005 | EP1542978A1 Novel bio-active molecules |
| 06/22/2005 | EP1542972A2 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use |
| 06/22/2005 | EP1542714A1 Methods of increasing platelet and hematopoietic stem cell production |
| 06/22/2005 | EP1542712A2 Glp-1 formulations with protracted time action |
| 06/22/2005 | EP1542705A1 Anticoagulant composition |
| 06/22/2005 | EP1455787B1 Certain glycine derivatives as factor xa inhibitors for use in the treatment of thrombotic disorders |
| 06/22/2005 | EP1372656B1 Pyrazolo[4,3-d]pyrimidinone compounds as cgmp pde inhibitors |
| 06/22/2005 | EP1345933B1 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 06/22/2005 | EP1320523B1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 06/22/2005 | EP1267915B1 Activated protein c for treating pancreatitis |
| 06/22/2005 | EP1196188B1 Vgf selective monoclonal antibodies and their use for treating vgf-related disorders |
| 06/22/2005 | EP1171136B1 Immunomodulating compositions comprising urea derivatives for use in the treatment of inflammatory diseases |
| 06/22/2005 | CN1630730A Methods for detecting and treating the early onset of aging-related conditions |
| 06/22/2005 | CN1630716A Hematopoietic cells from human embryonic stem cells |
| 06/22/2005 | CN1630714A Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression |
| 06/22/2005 | CN1630710A Compositions including ammonia oxidizing bacteria and methods of using same |
| 06/22/2005 | CN1630666A Factor VIII2 C2 domain variants |
| 06/22/2005 | CN1630657A Deazapurines and uses thereof |
| 06/22/2005 | CN1630644A Pyridine and pyrimidine derivatives |
| 06/22/2005 | CN1630640A Novel enantiomer of tetra hydrogen isoquinoline derivative and officinal salt, preparation and pharmaceutical composition thereof |
| 06/22/2005 | CN1630639A Novel pyridine- and quinoline-derivatives |
| 06/22/2005 | CN1630636A Indoline derivatives and their use as 5-HT2 receptor ligands |
| 06/22/2005 | CN1630635A Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these |
| 06/22/2005 | CN1630535A Inhibition of STAT-1 |
| 06/22/2005 | CN1630527A Methods and compositions for oxygen transport comprising a high oxygen affinity |
| 06/22/2005 | CN1630516A Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 06/22/2005 | CN1630515A Compounds active at the glucocorticoid receptor II |
| 06/22/2005 | CN1630510A Atorvastatin calcium in a pharmaceutical form, composition thereof, and pharmaceutical formulation comprising atorvastatin calcium |
| 06/22/2005 | CN1629190A A protein, gene and pharmaceutical use thereof |
| 06/22/2005 | CN1629128A Method for preparing leucogen materials and leucogen tablets |
| 06/22/2005 | CN1628845A Compound medicinal formulation with bioactivity |
| 06/22/2005 | CN1628833A Formulation of 'Duyiwei' with improved bioavailability and drug effect and preparation process thereof |
| 06/22/2005 | CN1628795A Formulation for treating cardiovascular and cerebrovascular disease and its preparation process and quality control method |
| 06/22/2005 | CN1628785A Quick acting Chinese medicine for dissolving thrombolysis and dredging collaterals and its preparation method |
| 06/22/2005 | CN1628784A Compound fineleaf schizonepeta oil soft capsule |
| 06/22/2005 | CN1628729A Pharmaceutical composition and usage |
| 06/22/2005 | CN1628694A The second purpose of Siberian solomonseal rhizome polysaccharide |
| 06/22/2005 | CN1628693A Glossy ganoderma preparation containing main active substance of glossy ganoderma herb and preparing method thereof |
| 06/22/2005 | CN1628678A Thrombosis deroppilation orally disintegrating tablet and preparation method thereof |
| 06/22/2005 | CN1207302C Method and compounds for curing diseases caused by mutations |
| 06/22/2005 | CN1207294C Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors |
| 06/22/2005 | CN1207056C Peptide-containing & alpha; -ketoamide cysteine and serine protease inhibitors |
| 06/22/2005 | CN1207037C Novel usage of Japanese honewort |
| 06/22/2005 | CN1207004C Freeze-dried plasma without blood group and its preparation method |
| 06/22/2005 | CN1206982C Stable protein: phospholipid compositions and methods |
| 06/22/2005 | CA2487107A1 Novel targets for obesity from skeletal muscle |
| 06/21/2005 | US6909014 Intermediates for the synthesis of ether compounds |
| 06/21/2005 | US6908987 Comprises nucleotide sequences coding peroxisome proliferator activator receptor protein (PCG) for modulating thermogenesis in adipocytes and treating obesity |
| 06/21/2005 | US6908943 Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of disease |
| 06/21/2005 | US6908609 Removing fluid from the intestinal tract of a host by directly delivering an effective amount of water-absorbent polymer to the intestinal tract |
| 06/21/2005 | CA2182303C Method of preparing a viral vector by homologous intermolecular recombination |
| 06/21/2005 | CA2145749C Thrombin activatable plasminogen derivatives |
| 06/16/2005 | WO2005054252A1 Crystal of hydrochloride of sulfoxide derivative |
| 06/16/2005 | WO2005053743A1 Immunologic compounds for prevention, protection, prophylaxis or treatment of immunological disorders, infections and cancer |
| 06/16/2005 | WO2005010051A3 Heparin-derived oligosaccharide mixtures, preparation thereof and pharmaceutical compositions containing said mixtures |
| 06/16/2005 | WO2004093881A3 Use of dipyridamole or mopidamole for treatment and prevention of thrombo-embolic diseases and disorders caused by excessive formation of thrombin and/or by elevated expression of thrombin receptors |
| 06/16/2005 | WO2004048565A9 Apoptosis-associated protein and use thereof |
| 06/16/2005 | WO1990004979A8 Method of preventing or reducing eosinophilia |
| 06/16/2005 | US20050131060 Spirolaxine acts as active principle for treatment of those pathologies responding to activation of PPAR gamma receptor, such as acute malignant haemopathies. and Type 2 insulin-resistant diabetes |
| 06/16/2005 | US20050131049 Derivatives of aryl (or heteroaryl) azolylcarbinoles for the treatment of urinary incontinence |
| 06/16/2005 | US20050131023 Use of pleuromutilins for the treatment of disorders caused by helicobacter pylori |
| 06/16/2005 | US20050131016 Chemical compounds |
| 06/16/2005 | US20050131005 4-azasteroid derivatives as androgen receptor modulators |
| 06/16/2005 | US20050130935 Combination of a beta-2-adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders |
| 06/16/2005 | US20050130902 Upregulate expression of a gene encoding an antioxidative anzyme, such as superoxide dismutase or catalase; neurodegenerative, cardiovascular, cerebral, disorders, trauma, injuries, burns, cancer |
| 06/16/2005 | US20050130304 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 06/16/2005 | US20050130287 Purifying process of soluble proteins of the l.obliqua bristles through prothrombin activation: process for a partial determination of the amino acids sequence of the prothrombin activator; process for determining the prothrombin activation of fraction II, n-terminal and internal fragments sequences |
| 06/16/2005 | US20050130195 Functional molecule and process for producing the same |
| 06/16/2005 | US20050130145 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, and agonists; drug screening |
| 06/16/2005 | US20050130127 Coronavirus-like particles comprising functionally deleted genomes |
| 06/16/2005 | US20050129667 treating leukemia or bone cancer by injecting a samarium comples of ethylenediaminetetramethanephosphonic acid and another chemotherapeutic agent; stem cell/bone marrow transplantation and/or restoration; patient is not subjected to total body irradiation |
| 06/16/2005 | CA2547887A1 Protein modifier production inhibitor |
| 06/15/2005 | EP1541589A1 Fused protein with the function of both hemolysis and anticoagulation and the use of it |
| 06/15/2005 | EP1541560A1 Novel tetrahydroquinoline derivatives |
| 06/15/2005 | EP1541175A2 Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions |
| 06/15/2005 | EP1539933A2 Methods of organ regeneration |
| 06/15/2005 | EP1539816A1 Thrombin-cleavable factor x analogues |
| 06/15/2005 | EP1539769A1 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 06/15/2005 | EP1539763A1 Azaindole kinase inhibitors |
| 06/15/2005 | EP1539762A2 Bicyclic pyrimidinones as coagulation cascade inhibitors |
| 06/15/2005 | EP1539732A1 Novel compounds |
| 06/15/2005 | EP1539727A2 Compounds, compositions, and methods |
| 06/15/2005 | EP1539701A1 Caspase inhibitors and uses thereof |
| 06/15/2005 | EP1539696A2 Process for preparing quinolin antibiotic intermediates |
| 06/15/2005 | EP1539695A1 N-4-piperidinyl compounds as ccr5 modulators |
| 06/15/2005 | EP1539686A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 06/15/2005 | EP1539683A2 Phenol derivatives and their use as rotamase inhibitors |
| 06/15/2005 | EP1539679A2 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use |
| 06/15/2005 | EP1539678A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands |
| 06/15/2005 | EP1539674A1 Amino-propanol derivatives |
| 06/15/2005 | EP1539284A2 Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| 06/15/2005 | EP1539236A2 Compositions, methods and kits relating to anti-platelet autoantibodies and inhibitors thereof |
| 06/15/2005 | EP1539170A2 Stabilized formulations of alpha adrenergic receptor antagonists and uses thereof |
| 06/15/2005 | EP1539120A1 Combination of an ibat inhibitor and a metal salt for the treatment of diarrhoea |
| 06/15/2005 | EP1539103A2 Methods of treating idiopathic pulmonary fibrosis |
| 06/15/2005 | EP1538913A2 Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| 06/15/2005 | EP1325007B1 Hexahydropyrazino[1'2':1,6]-pyrido[3,4-b]indole-1,4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction |
| 06/15/2005 | EP1198255A4 Identification of compounds that modify transcriptional responses to hypoxia |